Trade Gilead ^GILD

Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades

Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD

BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD

Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Brokerages - Markets Daily

Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD

Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Upgraded by Wall Street Zen to Strong-Buy Rating

BNP Paribas Sells 16,020 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Goldman Sachs Healthcare Stocks: Top 10 Stock Picks

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen

Harvest Fund Management Co. Ltd Has $10.34 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political

Dodge & Cox Reduces Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

EHP Funds Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Daily Political

Analysts Set Expectations for Gilead Sciences Q1 Earnings - Markets Daily

Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD

Johnson Financial Group Inc. Lowers Stake in Gilead Sciences, Inc. $GILD - Daily Political

How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story

Gilead Sciences Sees Unusually Large Options Volume (NASDAQ:GILD) - Daily Political

Investors Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD) - Zolmax

Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)

Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals

Inceptionr LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily

Bokf Na Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - Daily Political

Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political

3 Top-Rated Stocks to Buy to Hedge Against Stagflation as Middle East Conflict Drags On

Mackenzie Financial Corp Lowers Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - Stock Observer

Gilead Sciences, Inc. (GILD) to Issue Quarterly Dividend of $0.82 on March 30th - Stock Observer

CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

Jefferies Financial Group Begins Coverage on Gilead Sciences (NASDAQ:GILD) - Markets Daily

Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors

Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors

Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - Stock Observer

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts

Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion

Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD

Is New HIV Switch Data Reframing the Investment Case for Gilead Sciences' Lenacapavir Platform (GILD)?

Grantham Mayo Van Otterloo & Co. LLC Acquires 68,006 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Analysis of a PCORnet® database identifies multi-level predictors of delta hepatitis in a U.S. hotspot

Vestcor Inc Has $24.88 Million Stake in Gilead Sciences, Inc. $GILD - Markets Daily

Swiss National Bank Has $398 Million Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Purchased by WINTON GROUP Ltd

Bringing it home: SA is leading the charge to make anti-HIV jab for Africa

Gilead Sciences, Inc. $GILD Shares Bought by Kiltearn Partners LLP

Gilead Sciences, Inc. $GILD Shares Acquired by Vinva Investment Management Ltd - Stock Observer

Natixis Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Parallel Advisors LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD

Korea Investment CORP Boosts Holdings in Gilead Sciences, Inc. $GILD

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $2.81 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Blair William & Co. IL

Rhenman & Partners Asset Management AB Sells 88,000 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run

Is It Too Late To Consider Gilead Sciences (GILD) After Its Strong Multi‑Year Rally?

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Gilead Sciences (GILD) | Markets Insider

Gilead Sciences, Inc. $GILD Shares Purchased by HUB Investment Partners LLC

First Trust Advisors LP Boosts Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Position Lifted by Orion Porfolio Solutions LLC

Kingsview Wealth Management LLC Trims Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Bought by Fisher Asset Management LLC

Gilead Sciences discovers KRAS G12D mutant inhibitors | BioWorld

Gilead Sciences, Inc. $GILD Stake Cut by Pitcairn Co. - Daily Political

Stonebridge Capital Advisors LLC Sells 9,029 Shares of Gilead Sciences, Inc. $GILD

South Dakota Investment Council Cuts Stake in Gilead Sciences, Inc. $GILD

Picton Mahoney Asset Management Boosts Position in Gilead Sciences, Inc. $GILD

Crossmark Global Holdings Inc. Grows Stake in Gilead Sciences, Inc. $GILD

Preclinical data support continued testing of Gilead's HIV candidate GS-3242 | BioWorld

Dimensional Fund Advisors LP Reduces Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by CI Investments Inc.

Victory Capital Management Inc. Boosts Stake in Gilead Sciences, Inc. $GILD

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control

Gilead Sciences, Inc. $GILD Shares Sold by APG Asset Management N.V.

Assessing Gilead Sciences (GILD) Valuation As Recent Share Price Momentum Meets Conflicting Fair Value Signals

Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Multi Year Share Price Run

Gilead Sciences, Inc. $GILD Shares Sold by DNB Asset Management AS

Argent Trust Co Buys 21,785 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Holdings Cut by Rafferty Asset Management LLC - Daily Political

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk